Cancer diagnostics expanding NAT applications — the emerging application of molecular diagnostics and nucleic acid detection technology to cancer diagnostics — including circulating tumor DNA (ctDNA) detection, minimal residual disease (MRD) monitoring through blood-based liquid biopsy, and tumor-specific mutation analysis — creating a premium diagnostics market segment whose...